JD Supra

CTA: FinCEN Clarifies Ownership Interests Must be Entirely Controlled or Wholly Owned to Qualify for the Subsidiary Exemption

On January 12, 2024, the U.S. Department of the Treasury’s Financial Crimes Enforcement Network (“FinCEN”) released additional FAQs[1] in response to questions received regarding compliance with ...

transcosmos's Vietnam-based system development subsidiary signs MoU with Ho Chi Minh City University of Foreign Languages and Information Technology (HUFLIT)

Vietnam co., Ltd. (Headquarters: Ho Chi Minh, Vietnam; CEO: Daisuke Kamada; transcosmos technology Vietnam), its wholly owned ...
The Caledonian-Record

Chilean Cobalt Corp. Announces Completion of Strategic Equity Investment by Glencore and Madesal

BERWYN, PA / ACCESS Newswire / December 3, 2025 / Chilean Cobalt Corp. (OTCQB:COBA) ("Chilean Cobalt" or the "Company") is ...
GovCon Wire

Onepath Systems Becomes Wholly-owned Subsidiary of Albers Aerospace

Albers Aerospace has completed its deal to take over Onepath Systems, a turnkey services provider to the Department of Defense now a wholly-owned subsidiary of the former. As a result of the ...

Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms

ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced the ...
Democrat and Chronicle

Envirotech Vehicles, Inc. And Its Wholly Owned Subsidiary Maddox Industries Manufacture 5 Million Isolation Gowns For The U.S. Government As Part of 35 Million Gown Contract ...

HOUSTON, TEXAS / ACCESS Newswire / September 16, 2025 / Envirotech Vehicles, Inc. (NASDAQ:EVTV) (the “Company” or “Envirotech Vehicles”), a leader in advanced transportation and defense innovation, ...
Business Wire

MAIA Biotechnology, Inc. Establishes Wholly Owned Subsidiaries in Romania and Australia to Support Global Development of THIO

CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on developing potential first-in-class oncology drugs (“MAIA”), announced today that the company ...